首页> 外文期刊>Journal of clinical virology: The official publication of the Pan American Society for Clinical Virology >Antigenic complementarity among AIDS-associated infectious agents and molecular mimicry of lymphocyte proteins as inducers of lymphocytotoxic antibodies and circulating immune complexes.
【24h】

Antigenic complementarity among AIDS-associated infectious agents and molecular mimicry of lymphocyte proteins as inducers of lymphocytotoxic antibodies and circulating immune complexes.

机译:艾滋病相关感染因子之间的抗原互补和作为淋巴细胞毒性抗体和循环免疫复合物诱导剂的淋巴细胞蛋白的分子模拟。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: People at risk for acquired immunodeficiency syndrome (AIDS) have high rates of cofactor infections in addition to HIV, including cytomegalovirus, hepatitis viruses, Mycobacteria, Mycoplasmas, and Staphylococcus aureus. Most people with AIDS also develop lymphocytotoxic antibodies (LCTA) and circulating immune complexes (CIC). While HIV proteins mimic HLA antigens, many cofactor agents mimic CD4 antigens. It has therefore been proposed that cofactor infections may interact with HIV by producing complementary antigens that induce LCTA and CIC, and that the resulting immunological dysfunction is part of AIDS pathogenesis. OBJECTIVES: To test (1) whether HIV and its cofactor infections elicit complementary (idiotype-anti-idiotype) antibodies, and (2) if any of these antibodies mimic anti-lymphocyte antibodies. STUDY DESIGN: Two immunological methods are employed to test for antibody complementarity: (1) double antibody diffusion, a modification of Ouchterlony immunodiffusion, in which antibodies are tested for their ability to precipitate each other; (2) double-antibody ELISA, in which an antibody against one infectious agent is adsorbed to an ELISA plate and an antibody against a second agent is used to detect the first. RESULTS: Data on over a thousand double antibody diffusion (DAD) and about 70 DA-ELISA experiments are reported. These show that only specific pairs of antibodies are complementary: HIV-CMV; HIV-HBV; HIV-tuberculosis; HIV-mycoplasmas; HIV-S. aureus; and CMV-mycoplasmas. In addition, HIV antibodies precipitate CD4 antibodies; CMV antibodies precipitate HLA-DR antibodies; while mycobacteria and mycoplasma antibodies precipitate macrophage antibodies. CONCLUSIONS: Antibodies elicited by HIV infection can interact with antibodies elicited by cofactor infections to form CIC, and some of these antibodies mimic lymphocyte antibodies so that they may function as LCTA. Since LCTA and CIC are associated with increased lymphocyte death in AIDS, the immune response against cofactors in HIV may play a significant role in AIDS pathogenesis. The fact that both HIV and cofactors elicit antibodies with LCTA characteristics may pose problems for vaccine development.
机译:背景:除艾滋病毒外,有获得性免疫缺陷综合症(AIDS)风险的人还具有较高的辅因子感染率,包括巨细胞病毒,肝炎病毒,分枝杆菌,支原体和金黄色葡萄球菌。大多数患有艾滋病的人也会产生淋巴细胞毒性抗体(LCTA)和循环免疫复合物(CIC)。当HIV蛋白模拟HLA抗原时,许多辅助因子试剂模拟CD4抗原。因此,已经提出,辅因子感染可通过产生诱导LCTA和CIC的互补抗原而与HIV相互作用,并且所导致的免疫功能障碍是AIDS发病机理的一部分。目的:测试(1)HIV及其辅助因子感染是否引起互补性(独特型-抗独特型)抗体,以及(2)这些抗体中的任何一种是否模仿抗淋巴细胞抗体。研究设计:采用两种免疫学方法测试抗体的互补性:(1)双重抗体扩散,一种Ouchterlony免疫扩散的修饰,其中测试抗体彼此沉淀的能力; (2)双重抗体ELISA,其中将针对一种传染剂的抗体吸附至ELISA板,并且针对第二种试剂的抗体用于检测第一种。结果:报道了超过一千种双抗体扩散(DAD)的数据和约70个DA-ELISA实验。这些表明只有特定的抗体对才是互补的:HIV-CMV;抗体对。 HIV-HBV;艾滋病毒结核病; HIV支原体; HIV-S。金黄色和CMV支原体。此外,HIV抗体会沉淀CD4抗体。 CMV抗体沉淀HLA-DR抗体;而分枝杆菌和支原体抗体沉淀巨噬细胞抗体。结论:HIV感染引起的抗体可以与辅因子感染引起的抗体发生相互作用,形成CIC,其中一些抗体模仿淋巴细胞抗体,因此它们可以起LCTA的作用。由于LCTA和CIC与AIDS中淋巴细胞死亡的增加有关,因此针对HIV中辅助因子的免疫应答可能在AIDS发病机理中起重要作用。 HIV和辅因子均会引发具有LCTA特征的抗体,这一事实可能会给疫苗开发带来问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号